Literature DB >> 9657426

Post-translational modifications required for coagulation factor secretion and function.

R J Kaufman1.   

Abstract

Mesh：

Substances：

Year:  1998        PMID： 9657426

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  21 in total

Review 1.  From the ER to the golgi: insights from the study of combined factors V and VIII deficiency.

Authors:  W C Nichols; D Ginsburg
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

2.  N-Glycan-calnexin interactions in human factor VII secretion and deficiency.

Authors:  Hao Wang; Lina Wang; Shuo Li; Ningzheng Dong; Qingyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2019-06-08       Impact factor: 5.085

Review 3.  Animal models of hemophilia.

Authors:  Denise E Sabatino; Timothy C Nichols; Elizabeth Merricks; Dwight A Bellinger; Roland W Herzog; Paul E Monahan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

4.  Hepatocyte Is a Sole Cell Type Responsible for the Production of Coagulation Factor IX In Vivo.

Authors:  Kohei Tatsumi; Kazuo Ohashi; Shigeki Mukobata; Atsushi Kubo; Fumikazu Koyama; Yoshiyuki Nakajima; Midori Shima; Teruo Okano
Journal:  Cell Med       Date:  2012-05-14

Review 5.  Recent developments in the understanding of the combined deficiency of FV and FVIII.

Authors:  Bin Zhang
Journal:  Br J Haematol       Date:  2009-01-16       Impact factor: 6.998

Review 6.  Molecular approaches for improved clotting factors for hemophilia.

Authors:  Randal J Kaufman; Jerry S Powell
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113

7.  Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency.

Authors:  Lara Rizzotto; Mirko Pinotti; Paolo Pinton; Rosario Rizzuto; Francesco Bernardi
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

8.  Coagulation Factor IX for Hemophilia B Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov
Journal:  Acta Naturae       Date:  2012-04       Impact factor: 1.845

9.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18

Review 10.  The relationship between ABO blood group, von Willebrand factor, and primary hemostasis.

Authors:  Soracha E Ward; Jamie M O'Sullivan; James S O'Donnell
Journal:  Blood       Date:  2020-12-17       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.